<DOC>
	<DOCNO>NCT00965926</DOCNO>
	<brief_summary>The purpose study evaluate effect food intake pharmacokinetics YM178 healthy , non-elderly adult subject .</brief_summary>
	<brief_title>A Study Investigate Food Effect Pharmacokinetics YM178 Healthy , Non-elderly Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Healthy judge investigator/subinvestigator base result physical examination lab test Body weight ( screen ) ; female ≥40.0 kg , &lt; 70.0 kg , male ≥50.0 kg , &lt; 80.0 kg BMI ( screen ) : ≥17.6 , &lt; 26.4 Written inform consent obtain Received investigational drug within 120 day screen test Donated 400 mL whole blood within 90 day , 200 mL whole blood within 30 day , blood component within 14 day screen test Received medication within 7 day hospital admission schedule receive medication Females lactating , pregnant , potentially childbearing , willing get pregnant study period History drug allergy Upper gastrointestinal disease ( e.g . nausea , vomit , stomachache ) within 7 day hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Overactive Bladder</keyword>
	<keyword>Urinary incontinence</keyword>
	<keyword>YM178</keyword>
	<keyword>mirabegron</keyword>
</DOC>